Vincerx Pharma Stock Price on December 14, 2024
| VINC Stock | USD 0.19 0.01 5.00% |
Below is the normalized historical share price chart for Vincerx Pharma extending back to May 27, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Vincerx Pharma stands at 0.19, as last reported on the 14th of December 2024, with the highest price reaching 0.20 and the lowest price hitting 0.18 during the day.
If you're considering investing in Vincerx Stock, it is important to understand the factors that can impact its price. Vincerx Pharma owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.25, which indicates the firm had a -0.25% return per unit of risk over the last 3 months. Vincerx Pharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vincerx Pharma's Risk Adjusted Performance of (0.17), coefficient of variation of (401.65), and Variance of 46.54 to confirm the risk estimate we provide.
As of December 14, 2024, Total Stockholder Equity is expected to decline to about 10.7 M. In addition to that, Common Stock Total Equity is expected to decline to 800.00. At present, Vincerx Pharma's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 2.35, whereas Price Earnings Ratio is forecasted to decline to (0.66). Vincerx Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of May 2020 | 200 Day MA 1.5313 | 50 Day MA 0.5429 | Beta 1.267 |
Vincerx |
Sharpe Ratio = -0.2497
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VINC |
Estimated Market Risk
| 6.93 actual daily | 61 61% of assets are less volatile |
Expected Return
| -1.73 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.25 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Vincerx Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vincerx Pharma by adding Vincerx Pharma to a well-diversified portfolio.
Price Book 0.6835 | Book Value 0.521 | Enterprise Value -1.6 M | Enterprise Value Ebitda (3.13) | Shares Float 23.7 M |
Related Headline
Iovance Biotherapeutics Headline on 13th of December 2024
SkyView Investment Advisors LLC Invests 188,000 in Iovance B... by thelincolnianonline.com
SkyView Investment Advisors LLC bought a new position in Iovance Biotherapeutics, Inc. during the 3rd quarter, Holdings Channel reports. The institutional investor bought 20,000 shares of the biotechnology companys stock, valued at approximately 188,000. Several other institutional investors and hedge funds have also recently modified their holdings of the business. XML
Vincerx Pharma Valuation on December 14, 2024
It is possible to determine the worth of Vincerx Pharma on a given historical date. On December 14, 2024 Vincerx was worth 0.19 at the beginning of the trading date compared to the closed value of 0.19. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vincerx Pharma stock. Still, in general, we apply an absolute valuation method to find Vincerx Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vincerx Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vincerx Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 0.21 | 0.21 | 0.18 | 0.19 | 690,769 | |
12/13/2024 | 0.19 | 0.20 | 0.18 | 0.19 | 703,677 |
| Backtest Vincerx Pharma | | | Vincerx Pharma History | | | Vincerx Pharma Valuation | Previous |
Vincerx Pharma Trading Date Momentum on December 14, 2024
| On December 13 2024 Vincerx Pharma was traded for 0.19 at the closing time. The top price for the day was 0.20 and the lowest listed price was 0.18 . The trading volume for the day was 703.7 K. The trading history from December 13, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 0.00% . |
Vincerx Pharma Fundamentals Correlations and Trends
By evaluating Vincerx Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vincerx Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vincerx financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Vincerx Pharma Stock history
Vincerx Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vincerx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vincerx Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vincerx Pharma stock prices may prove useful in developing a viable investing in Vincerx Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 21.3 M | 17.3 M | |
| Net Loss | -58.8 M | -55.9 M |
Vincerx Pharma Stock Technical Analysis
Vincerx Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Vincerx Pharma Period Price Range
Low | December 14, 2024
| High |
0.00 | 0.00 |
Vincerx Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Vincerx Pharma December 14, 2024 Market Strength
Market strength indicators help investors to evaluate how Vincerx Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vincerx Pharma shares will generate the highest return on investment. By undertsting and applying Vincerx Pharma stock market strength indicators, traders can identify Vincerx Pharma entry and exit signals to maximize returns
Vincerx Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vincerx Pharma's price direction in advance. Along with the technical and fundamental analysis of Vincerx Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vincerx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (1.77) | |||
| Total Risk Alpha | (2.56) | |||
| Treynor Ratio | (2.62) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Vincerx Stock analysis
When running Vincerx Pharma's price analysis, check to measure Vincerx Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vincerx Pharma is operating at the current time. Most of Vincerx Pharma's value examination focuses on studying past and present price action to predict the probability of Vincerx Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vincerx Pharma's price. Additionally, you may evaluate how the addition of Vincerx Pharma to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |